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Background: The clinical presentations and survival patterns of infants with trisomy 
18 have changed with increasing utilization of prenatal ultrasound and amniocentesis, 
and improvements in neonatal intensive care.
Methods: We obtained data on duration of survival, male to female ratio, and clinical 
details for patients with trisomy 18, and calculated the prevalence rate.
Results: We studied 31 consecutive trisomy 18 infants. The estimated prevalence 
was 1/4,144. Eleven (35%) were premature infants, and 20 (65%) were full term. 
Mean birth weight was 1,896 g. Median life expectancy was 12 days; 11 days for males 
and 14 days for females (p = 0.87). The short-term survival rates of 1 week, 4 weeks, 
and 6 months were 58%, 32%, and 10%, respectively. The long-term survival rates 
of 1 year, 2 years, and 3 years were 6%, 6%, and 3%, respectively. Families signed 
do-not-resuscitate consent forms for five male (50%) and 19 female infants (90%) 
(p = 0.043).
Conclusion: All trisomy 18 infants in this study were preterm or full-term deliveries. 
Mean birth weight was lower than previously reported, and a high percentage of 
families signed do-not-resuscitate consent forms. Females did not survive longer 
than males, due to more females not being resuscitated. Most infants died in the 
first few weeks of life, but 3−6% of infants lived for ≥ 1 year. The possibility of long-
term survival should be considered when counseling parents regarding trisomy 18.
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1. Introduction
Trisomy 18, also known as Edwards syndrome, is the 
second most common trisomy after trisomy 21, with 
an incidence of approximately 1 per 3,000−8,000 
births.1−3 Continuing improvements in the quality 
of prenatal ultrasound and increased utilization of 
amniocentesis have made second- and third-
trimester diagnosis of trisomy 18 more common. 
Counseling of parents on prognosis for this condition 
is critical in order for families and physicians to be 
able to make informed decisions regarding delivery 
management and newborn care. Parents are invari-
ably distressed when confronted with a neonate 
with the characteristic clinical features of trisomy 
18,1,4 and objective advice about average survival 
time and the possible range of life spans are essen-
tial components of medical care and counseling.
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Survival patterns and clinical details of these 
infants have been published previously,5−8 but due 
to the improvements in neonatal intensive care, 
earlier diagnosis and changes in medical manage-
ment, the clinical presentations and survival pat-
terns have recently changed. We studied these 
important aspects of trisomy 18 based on the ex-
perience of a medical center in mid-Taiwan.
2. Materials and Methods
This study included index cases of infants with tri-
somy 18 diagnosed by cytogenetic studies in 
Changhua Christian Hospital from January 1991 to 
December 2006. The diagnosis of trisomy 18 was 
based on prenatal genetic analysis following amnio-
centesis (3 cases) or postnatal chromosome studies 
(28 cases). The three amniocenteses were per-
formed during the 26th, 27th, and 30th weeks of 
gestation, and therapeutic abortions were not per-
formed because of delayed diagnosis. Two sources 
of information were used for this total population 
study: Workbooks and laboratory registers from the 
cytogenetic laboratory were examined, and hospital 
case records and medical charts were reviewed. 
We identified 31 infants over the 16-year period. 
The prevalence rate in live newborns was calcu-
lated. Survival estimates were obtained, using
information on age at death, male-to-female ratio, 
and other relevant clinical details. The survival of 
male and female infants was compared using 
the log-rank test. The percentages of families sign-
ing do-not-resuscitate consent forms for male
and female infants were compared using the
χ2 test. p values < 0.05 were considered to be
significant.
3. Results
Thirty-one cases were identified from 1991 to 2006; 
13 of them were born at Changhua Christian Hospital 
and 18 were referred from obstetric clinics. Out of a 
total of 53,874 live births, the estimated prevalence 
of trisomy 18 in our hospital was 1 per 4,144. Females 
were predominant; there were 10 males (32%) and 
21 females (68%). The median gestation period was 
37 weeks (range 26−41 weeks). Eleven cases (35%) 
were premature and 20 (65%) were full term. The 
mean birth weight was 1,896 g (range 1,028−2,760 g). 
Sixteen cases (52%) were born by vaginal delivery, 
and 15 (48%) by Cesarean section. The median life 
expectancy for all live-born infants with trisomy 18 
was 12 days (range 1 day−3 years). The median ages 
at death in males and females were 11 and 14 days, 
respectively, but this difference was not significant 
(p = 0.87). The short-term survival rates of 1 week, 
1 month, and 6 months were 58%, 32%, and 10%, 
respectively. The long-term survival rates of 1 year, 
2 years, and 3 years were 6%, 6%, and 3%, respectively. 
The survival curve from this study is compared with 
those from Weber’s report in 1967,5 Young et al in 
1986,9 Root and Carey in 1994,2 and Lin et al in 2006 
in Table 1 and Figure, derived from Root and Carey.2
The incidences of the clinical features are listed 
in Table 2. The most common clinical feature was in-
trauterine growth retardation (90%). None of our in-
fants underwent surgery during the neonatal period. 
All of the 31 cases demonstrated complete trisomy 
18, and no mosaic form was found. The sibling’s re-
currence rate was zero in this study. Twenty-four 
families (77%) signed do-not-resuscitate consent 
forms after trisomy 18 was diagnosed; five were 
for male infants (50%) and 19 for female infants 
(90%) (p = 0.043).
Table 1 Survival of live-born with trisomy 18
Age/
 New York Utah  Leicester Taipei Changhua
 Weber, 1967 Root, 1994 Young et al, 1986 Lin et al, 2006 Hsiao et al, 2007
% surviving
 n = 192 n = 64 n = 21 n = 39 n = 31
Birth 100 100 100 100 100
1 d 98 86 67 95 90
1 wk 89 45 32 46 58
2 wk 81 41  27 45
1 mo 72 34 18 16 32
2 mo 51.8 22  11 14
3 mo 38 20  5 
4 mo 30 14  5 
5 mo 23 9 0 3 
6 mo 13 9  3 10
1 yr 8 5  3 6
2 yr 5 5  3 6
3 yr 3 5  3 3
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4. Discussion
The rates of trisomy 18 reported in the literature 
range from 1:3,000−1:8,000 livebirths.1,3,10 We
estimated the prevalence at birth in our hospital to 
be about 1:4,144, which is in agreement with other 
recent reports.2,6,7 This may be an over-estimate, 
because of selection bias. Compared with Weber’s 
data,5 our results showed a shorter survival time. 
However, it is not surprising that recent studies 
should show shorter survival times, since in the 
1960s, trisomy 18 was typically not diagnosed until 
infants were 2 months old. More recent studies 
using population-based data from Denmark,7 
Australia,6 England,9 and Utah2 concluded that 
survival in infants with trisomy 18 was poorer than 
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Figure Comparison of survival studies.
Table 2 Common clinical features in trisomy 18: total 31 cases
 Cases Frequency (%)
Intrauterine growth retardation 28 90
Congenital heart disease 24 77
Low-set, malformed ear 22 71
Small oral opening 19 61
Micrognathia 18 58
Characteristic overlapping hand 18 58
Prominent occiput 17 55
Rocker bottom feet 16 52
Hypotonia or hypertonia 16 52
Microcephaly 16 52
Prematurity 11 35
Short sternum 10 32
Small nipples 9 29
Hypoplastic or absent thumb 9 29
Syndactyly of toes or fingers 8 26
Small pelvis 8 26
Thrombocytopenia 8 26
Short palpebral fissure 7 22
Short hallux 6 22
Narrow palatal arch 6 22
Corneal opacification 5 16
Choanal atresia 4 13
Ulnar or radial deviation of hands 4 13
Single umbilical artery 3 10
Inguinal or umbilical hernia 3 10
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previously reported, either due to previous under-
diagnosis,11 or to changes in medical management. 
Even though trisomy 18 infants have multiple struc-
tural abnormalities, as listed in Table 2, none of our 
infants underwent surgery during the neonatal pe-
riod, compared with 13% reported in one textbook1 
and 42% in a Japanese study.12 This is because more 
cases were diagnosed early, and because of the 
high percentage (77%) of families who signed do-
not-resuscitate consent forms in our study.
Weber first reported that female trisomy 18 in-
fants lived longer than males,5 an observation that 
has been confirmed by later studies.2,8,9 In our study, 
however, there was no significant difference in 
survival between males and females. Many factors 
have the potential to affect survival rates, including 
gestational age; all of our infants were preterm or 
full-term deliveries. Differences in resuscitation 
efforts and life-support measures are also impor-
tant factors; because boys are more favored than 
girls in traditional Chinese families, more female 
than male infants’ families signed do-not-resuscitate 
consent forms after trisomy 18 was diagnosed. This 
seems to be the major factor affecting the dura-
tion of survival, and accounts for the fact that 
females did not live longer than males. Other prog-
nostic factors reported by Tanigawa et al13 revealed 
that prenatal ultrasonographic findings associated 
with survival of < 1 month included severe polyhy-
dramnios, absence of fluid in the stomach and 
severe cardiac anomaly, which are also important 
factors to consider when counseling parents.
The changes in gestational age and mean body 
weights of trisomy 18 infants were another impor-
tant finding of this study. According to Jones,1 one 
third of trisomy 18 cases were premature and one 
third were post-term, while 35% of trisomy 18 in-
fants in the current study were premature and 65% 
were term babies. There were no post-term infants. 
This discrepancy is probably due to advancements 
in prenatal care and ultrasound assessment; when 
poor weight gain is detected before term, obstetri-
cians urge the mother to deliver early, thus changing 
the infant’s natural course. These factors can ac-
count for the differences in gestational timing and 
smaller for date (mean birth weight 1,896 g) infants 
in our study, compared with those previously re-
ported in the literature (2,340 g).1
Although the survival of trisomy 18 infants was 
poorer than previously reported, and the fact that 
it is often assumed that trisomy 18 is a universally 
lethal condition, with all affected neonates dying 
within days of birth,14,15 a small but significant 
percentage of infants can survive the first 6 months 
to a year of life. Trisomy 18 is thus not universally 
lethal.2,6 Infants receiving intensive treatment in-
cluding Cesarean section, intubation with ventilator 
support, and surgical operations after birth, had 
median survival times as long as 152 days,12 and the 
survival rates at ages 1 week, 1 month, and 1 year 
were 88%, 83%, and 25%, respectively. We recom-
mend that counseling of parents of affected fetuses 
or neonates should include information on the fact 
that, although the majority of infants with trisomy 
18 die, some do survive. About 42% of newborns with 
trisomy 18 die in the first week of life, and 90% have 
died by 6 months of age. About 3−6% of trisomy 18 
infants in Taiwan are alive at 1 year of age. This 
information is important to providers who care for 
patients with these conditions and their families. 
However, these data are based on results from 
live-born infants, and should therefore be used 
cautiously for prenatal counseling, bearing in mind 
that a significant proportion of these pregnancies 
are expected to be lost before birth.16,17
5. Conclusions
All the trisomy 18 infants in this study were pre-
term or full-term deliveries. The mean birth weight 
was 1,896 g, which was lower than previously re-
ported, and a high percentage of families signed 
do-not-resuscitate consent forms after trisomy 18 
was diagnosed. Females did not survive longer than 
males, because more females were not being re-
suscitated. Most infants with trisomy 18 died in the 
first few weeks of life, but 3−6% of infants lived 
for ≥ 1 year. Early diagnosis, and changes in medical 
management and family’s attitudes seem to be the 
major factors affecting the duration of survival. The 
possibility of long-term survival should be considered 
when counseling parents regarding trisomy 18.
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